PP
ETTX

Paloma Partners’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Paloma Partners’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,891
Closed -$39K – 2409
2020
Q3 		$39K Buy
+18,891
New +$53.9K ﹤0.01% 1982

Other funds holding ETTX

PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Paloma Partners's ETTX Position: Q4 2020 in Review

Paloma Partners sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q4 2020, closing a stake of 18,891 shares — an estimated $39K sold.

Paloma Partners first reported a position in ETTX in Q3 2020 and held it in 1 quarter. The position peaked at $39K in Q3 2020. 25 funds tracked by Wall St. Rank hold ETTX as of Q4 2020.

  • Paloma Partners reported no remaining Entasis Therapeutics Holdings Inc. position as of Q4 2020 after selling out during the quarter.
  • Paloma Partners sold 18,891 Entasis Therapeutics Holdings Inc. shares in Q4 2020, an estimated $39K.
  • Paloma Partners first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2020 and held it in 1 quarter.
  • Paloma Partners's Entasis Therapeutics Holdings Inc. position peaked at $39K in Q3 2020.
  • 25 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.